Charles Schwab’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,042,988
Closed -$6.44M 3454
2020
Q3
$6.44M Sell
2,042,988
-279,855
-12% -$882K ﹤0.01% 1946
2020
Q2
$6.76M Sell
2,322,843
-604,578
-21% -$1.76M ﹤0.01% 1883
2020
Q1
$8.26M Sell
2,927,421
-546,524
-16% -$1.54M ﹤0.01% 1565
2019
Q4
$11.3M Sell
3,473,945
-198,177
-5% -$643K 0.01% 1609
2019
Q3
$7.93M Sell
3,672,122
-2,019
-0.1% -$4.36K ﹤0.01% 1734
2019
Q2
$11.5M Buy
3,674,141
+204,999
+6% +$644K 0.01% 1502
2019
Q1
$12.9M Sell
3,469,142
-335,327
-9% -$1.25M 0.01% 1423
2018
Q4
$11M Sell
3,804,469
-37,404
-1% -$108K 0.01% 1391
2018
Q3
$10.1M Buy
3,841,873
+266,275
+7% +$700K 0.01% 1630
2018
Q2
$8.37M Buy
3,575,598
+142,413
+4% +$333K 0.01% 1711
2018
Q1
$10.1M Buy
3,433,185
+301,466
+10% +$886K 0.01% 1486
2017
Q4
$8.58M Sell
3,131,719
-38,040
-1% -$104K 0.01% 1587
2017
Q3
$10.7M Buy
3,169,759
+292,654
+10% +$992K 0.01% 1377
2017
Q2
$7.11M Buy
2,877,105
+584,481
+25% +$1.44M 0.01% 1587
2017
Q1
$5.21M Buy
2,292,624
+263,273
+13% +$598K 0.01% 1739
2016
Q4
$4.3M Buy
2,029,351
+353,471
+21% +$749K ﹤0.01% 1826
2016
Q3
$5.62M Buy
1,675,880
+17,106
+1% +$57.3K 0.01% 1572
2016
Q2
$5.21M Sell
1,658,774
-69,382
-4% -$218K 0.01% 1531
2016
Q1
$5.76M Sell
1,728,156
-86,170
-5% -$287K 0.01% 1426
2015
Q4
$6.42M Buy
1,814,326
+121,789
+7% +$431K 0.01% 1340
2015
Q3
$8.51M Buy
1,692,537
+79,581
+5% +$400K 0.01% 1101
2015
Q2
$10.4M Sell
1,612,956
-3,223
-0.2% -$20.7K 0.01% 1003
2015
Q1
$11.4M Buy
1,616,179
+328,534
+26% +$2.31M 0.02% 909
2014
Q4
$9.93M Buy
1,287,645
+184,460
+17% +$1.42M 0.01% 899
2014
Q3
$8.24M Sell
1,103,185
-263,676
-19% -$1.97M 0.01% 971
2014
Q2
$13.2M Buy
1,366,861
+51,118
+4% +$495K 0.02% 645
2014
Q1
$10.9M Buy
1,315,743
+34,495
+3% +$287K 0.02% 738
2013
Q4
$10.8M Buy
1,281,248
+529,485
+70% +$4.47M 0.02% 668
2013
Q3
$6.08M Buy
751,763
+130,147
+21% +$1.05M 0.01% 1010
2013
Q2
$4.85M Buy
+621,616
New +$4.85M 0.01% 1084